Ishikawa Satoru, Igari Hidetoshi, Yamagishi Kazutaka, Takayanagi Shin, Yamagishi Fumio
National Hospital Organization Chiba-East Hospital, Department of Respiratory Medicine, 673 Nitona-cho, Chuoh-ku, Chiba 260-8712, Japan; Japan Community Health Care Organization Funabashi Central Hospital, Department of Internal Medicine, 6-13-10 Kaijin, Funabashi, Chiba 273-8556, Japan.
National Hospital Organization Chiba-East Hospital, Department of Respiratory Medicine, 673 Nitona-cho, Chuoh-ku, Chiba 260-8712, Japan; Chiba University Hospital, Division of Infection Control and Treatment, 1-8-1 Inohana, Chuoh-ku, Chiba 260-8677, Japan.
J Infect Chemother. 2019 Jan;25(1):45-49. doi: 10.1016/j.jiac.2018.10.005. Epub 2018 Nov 7.
Cured or completed cases in newly diagnosed sputum smear-positive pulmonary tuberculosis (TB) is 47.7% in Japan in 2016. Aging of TB patients and their underlying conditions could affect treatment outcome. We analyzed the association between the isolation of microorganisms from sputum at admission and the 180-day mortality rate of the sputum smear-positive pulmonary TB patients in Chiba-East Hospital in Japan. Total subjects were 761 (median age: 63 years). Sputum test for microorganisms was conducted in 708 patients. Microorganisms other than the normal oral flora were isolated in 128 cases (18.1%). Details of the isolated microorganisms were as follows: methicillin-resistant Staphylococcus aureus 23 cases, Klebsiella pneumoniae 17 cases, Pseudomonas aeruginosa 16 cases. Mortality was significantly elevated in the patients with those microorganisms than the others (39.8% vs. 10.2%) (P < 0.01). Fifty-one of 128 patients with those microorganisms died, and 10 of them died of infectious disease, which is the most frequent cause of deaths. The factors associated with the isolation of those microorganisms were as follows: respiratory failure (adjusted odds ratio (aOR):2.5 [95% confidence interval (CI) 1.3-4.7]), performance status 3 or 4 (aOR:2.9 [95% CI 1.6-5.4]), serum albumin <3.0 mg/dL (aOR:2.1 [95% CI 1.3-3.6], age of 65 years or older (aOR:2.0 [95% CI 1.2-3.4]). Those strains were isolated from one of sixth patients. Patients with those microorganisms did not always develop infectious diseases; however, treatment outcomes were poor, with higher mortality. The isolations of microorganisms were associated with various underlying conditions, leading to death. Thus, attention should be paid to TB patients with the above factors.
2016年,日本新诊断出的痰涂片阳性肺结核治愈或完成治疗的病例占47.7%。肺结核患者的老龄化及其基础疾病可能会影响治疗效果。我们分析了日本千叶东部医院痰涂片阳性肺结核患者入院时痰液中微生物的分离情况与180天死亡率之间的关联。总共有761名受试者(中位年龄:63岁)。对708名患者进行了痰液微生物检测。128例(18.1%)患者分离出了正常口腔菌群以外的微生物。分离出的微生物详情如下:耐甲氧西林金黄色葡萄球菌23例、肺炎克雷伯菌17例、铜绿假单胞菌16例。与其他患者相比,分离出这些微生物的患者死亡率显著升高(39.8%对10.2%)(P<0.01)。128例分离出这些微生物的患者中有51例死亡,其中10例死于传染病,这是最常见的死亡原因。与分离出这些微生物相关的因素如下:呼吸衰竭(校正优势比(aOR):2.5[95%置信区间(CI)1.3 - 4.7])、体能状态为3或4(aOR:2.9[95%CI 1.6 - 5.4])、血清白蛋白<3.0mg/dL(aOR:2.1[95%CI 1.3 - 3.6])、年龄6岁及以上(aOR:2.0[95%CI 1.2 - 3.4])。这些菌株在六分之一的患者中被分离出。分离出这些微生物的患者并不总是会患上传染病;然而,治疗效果较差,死亡率较高。微生物的分离与多种基础疾病相关,导致死亡。因此,应关注具有上述因素的肺结核患者。